Activated HSCs secrete endothelin-1 (ET-1), which is a molecule with potent vesoconstricting effect, promoting proliferation and fibrogenesis, and thus is supposed to contribute to portal hypertension (31, 32). The gene discussed is EDN1; the disease is portal hypertension.